general — 2026-07-06

Instructions

You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-da3dce4eaef26896: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-2f9fbdc9a994737e: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-c48124d4a6984e4e: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-1140f917db0aee9a: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-db3a24b5306b2f71: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-a7c5afc90668fa02: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-6a43e32f1042e3e4: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-651d3367f9c30100: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-3af6889b3bb8004b: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-df819143b1ebabad: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook